Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02071979 · ClinicalTrials.gov registry record · NA
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
A NA study, sponsored by Arteriocyte.
- Terminated
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
NCT02071979: Clinical Trial NA study, sponsored by Arteriocyte.
NCT02071979 is a NA study that was terminated before completion, run by Arteriocyte. The registered enrollment target is 1,500 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02071979, a NA study, was terminated before completion, sponsored by Arteriocyte.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
Study Summary
This study will examine differences in the process of wound-healing in patients treated with platelet rich plasma (a concentration of proteins derived from a patients own blood) applied to the wound as a gel; injected into the wound or surrounding tissue; or both; compared to patients treated with usual medical treatment . This study seeks to enroll patients who are 18 or older with a non-healing skin wound that is at least 30 days old. Only patients with Diabetic Foot Ulcers, Venous Ulcers, or Pressure Ulcers will be included in the study.
Primary Outcome
Wound size will be measured with ruler/probe for length, width and depth as well as with digital imaging. Wound size will be assessed in digital images taken of the wound.
Interventions
- DEVICE Autologous PRP Gel
- DEVICE Autologous PRP Injections
- DEVICE Autologous PRP Gel plus PRP Injections
- PROCEDURE Standard Wound Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2014-04 |
| Phase | NA |
Why NCT02071979 stopped before completion
NCT02071979 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 4 interventions - of which Autologous PRP Gel is the first listed.
NCT02071979 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02071979 about?
NCT02071979 is a clinical study titled "Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds". This study will examine differences in the process of wound-healing in patients treated with platelet rich plasma (a concentration of proteins derived from a patients own blood) applied to the wound as a gel; injected into the wound or surrounding tissue; or both; compared to patients treated with u...
What is the current status of trial NCT02071979?
This trial is currently terminated. It is a NA study. The enrollment target is 1,500 participants. The study started on 2014-04.
What interventions are being tested in trial NCT02071979?
The interventions under investigation include: Autologous PRP Gel (DEVICE), Autologous PRP Injections (DEVICE), Autologous PRP Gel plus PRP Injections (DEVICE), Standard Wound Care (PROCEDURE).
Who is sponsoring clinical trial NCT02071979?
This trial is sponsored by Arteriocyte, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02071979's enrollment target sits among peer trials
1,500 65th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia